The Europe Cluster Headache Market would witness market growth of 3.4% CAGR during the forecast period (2022-2028).
Cluster headache signs often appear between the ages of 20 and 40. Researchers traditionally believed that males experienced these headaches more frequently. But now cluster headaches are known to have an equal impact on both men and women. Smokers and heavy drinkers are also more likely to get cluster headaches. Cluster headache sufferers frequently also have sleep apnea. The precise etiology of cluster headaches is still a mystery to specialists. The first branch of the trigeminal nerve and the hypothalamus, a brain component of the autonomic nervous system, is involved in cluster headaches and trigeminal autonomic cephalgia.
In activators of a fresh cycle (round) of headaches most people have cluster headaches infrequently, once per several months or years. The recurrence of headaches frequently seems related to seasonal fluctuations. Many mistakenly believe they have allergies or sinusitis due to the relationship. There may be a connection between cluster headaches and the hypothalamus, as is thought to be the case. The "circadian clock," a built-in timetable that changes in response to sunlight, is located in this brain area.
In Italy, 3.9 million individuals use nicotine more often or for the first time, including through electronic cigarettes. According to the report, one in five people who occasionally use heated tobacco products has switched to regular use, particularly among young people. 3.9 million individuals, or 9% of the population, started using tobacco or increased their use during the lockdown. Of them, 8.5% smoked more cigarettes per day on average, upping their daily intake from 10.9 to 12.7, and most of those who did so were female. These factors driving the region's market growth
The Germany market dominated the Europe Cluster Headache Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $29.1 Million by 2028. The UK market is anticipated to grow at a CAGR of 2.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 4.1% during (2022 - 2028).
Based on Distribution channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Type, the market is segmented Episodic, and Chronic. Based on Drug Class, the market is segmented into Triptans, Calcium Channel Blockers, Ergot Derivatives, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Cluster Headache Market will Hit $437.5 Million by 2028, at a CAGR of 4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy’s Laboratories Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC (GSK), Pfizer, Inc., Fresenius SE & Co. KGaA, Eli Lilly And Company, Grünenthal GmbH, and Arrotex Pharmaceuticals Pty Limited.
By Distribution channel
By Type
By Drug Class
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 